Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC is listed as the manufacturer on 12 FDA drug label records covering 11 distinct active ingredients predominantly human prescription drug products.
About Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC is named as the labeler on 12 FDA drug label records. Its catalogue spans 11 distinct active ingredients, led by SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, CEFTOLOZANE AND TAZOBACTAM, DORAVIRINE, DORAVIRINE, ISLATRAVIR. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: treatment adult, determined fda-authorized, single agent, express pd-l, keytruda qlex, locally advanced, see dosage, unresectable metastatic. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | ORAL | 9 |
| — | — | INTRAVENOUS | 2 |
| — | — | SUBCUTANEOUS | 1 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Merck Sharp & Dohme LLC
| Brand name | Generic | Type | Route |
|---|---|---|---|
| DELSTRIGO | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | HUMAN PRESCRIPTION DRUG | ORAL |
| IDVYNSO | DORAVIRINE, ISLATRAVIR | HUMAN PRESCRIPTION DRUG | ORAL |
| JANUMET | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | HUMAN PRESCRIPTION DRUG | ORAL |
| JANUMET XR | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | HUMAN PRESCRIPTION DRUG | ORAL |
| KEYTRUDA | PEMBROLIZUMAB | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
| KEYTRUDA QLEX | PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH | HUMAN PRESCRIPTION DRUG | SUBCUTANEOUS |
| LIPFENDRA | LIPFENDRA | HUMAN PRESCRIPTION DRUG | ORAL |
| PIFELTRO | DORAVIRINE | HUMAN PRESCRIPTION DRUG | ORAL |
| SEGLUROMET | ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE | HUMAN PRESCRIPTION DRUG | ORAL |
| STEGLATRO | ERTUGLIFLOZIN | HUMAN PRESCRIPTION DRUG | ORAL |
| STEGLUJAN | ERTUGLIFLOZIN AND SITAGLIPTIN | HUMAN PRESCRIPTION DRUG | ORAL |
| ZERBAXA | CEFTOLOZANE AND TAZOBACTAM | HUMAN PRESCRIPTION DRUG | INTRAVENOUS |
Frequently asked questions
How many FDA drug products does Merck Sharp & Dohme LLC make?
12 FDA drug label records name Merck Sharp & Dohme LLC as the manufacturer, covering 11 distinct active ingredients.
What active ingredients does Merck Sharp & Dohme LLC produce?
The most frequent active ingredients in this portfolio are SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, CEFTOLOZANE AND TAZOBACTAM, DORAVIRINE, DORAVIRINE, ISLATRAVIR, DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE.
Are Merck Sharp & Dohme LLC products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.